Modulation of T-type Ca2+ channels by corticotropin-releasing factor through protein kinase C pathway in MN9D dopaminergic cells

Biochem Biophys Res Commun. 2007 Jul 6;358(3):796-801. doi: 10.1016/j.bbrc.2007.04.198. Epub 2007 May 8.

Abstract

Corticotrophin-releasing factor (CRF) is the main regulator of the body's stress axis and its signal is translated through G-protein-coupled CRF receptors (CRF-R1, CRF-R2). Even though CRF receptors are present in the midbrain dopamine neurons, the cellular mechanism of CRF action is not clear yet. Since voltage-dependent Ca(2+) channels are highly expressed and important in dopamine neuronal functions, we tested the effect of CRF on voltage-dependent Ca(2+) channels in MN9D cells, a model of dopamine neurons. The application of CRF-related peptide, urocortin 1, reversibly inhibited T-type Ca(2+) currents, which was a major Ca(2+) channel in the cells. The effect of urocortin was abolished by specific CRF-R1 antagonist and was mimicked by protein kinase C (PKC) activator, phorbol 12-myristate 13-acetate. PKC inhibitors abolished the effect of urocortin. These results suggest that urocortin modulates T-type Ca(2+) channel by interacting with CRF-R1 via the activation of PKC signal pathway in MN9D cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcium / metabolism
  • Cell Line
  • Cells, Cultured
  • Corticotropin-Releasing Hormone / metabolism*
  • Dopamine / metabolism*
  • Electrophysiology
  • Gene Expression Regulation*
  • Mice
  • Neurons / metabolism
  • Protein Kinase C / metabolism*
  • Signal Transduction
  • Tetradecanoylphorbol Acetate / chemistry
  • Time Factors
  • Urocortins

Substances

  • Urocortins
  • Corticotropin-Releasing Hormone
  • Protein Kinase C
  • Tetradecanoylphorbol Acetate
  • Calcium
  • Dopamine